Clinical Trial Update: Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating whether ondansetron can prevent neonatal abstinence syndrome in babies born to narcotic-dependent mothers has been completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcotic Addiction
• Neonatal Abstinence Syndrome

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: Stanford University | Conditions: Narcotic Addiction, Neonatal Abstinence Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2022-05-10